摘要:
The invention relates to the field of psychopharmacology. More particularly, the invention relates to the treatment of DSM-III disorders, such as impaired interpersonal and behavioral disorders, including sexual disorders such as M.E.D. and HS.D.D. The invention provides new therapeutic compositions and methods for treating DSM-III disorders, including M.E.D. and H.S.D.D. The compositions and methods according to the invention provide improved awareness and alertness to environment, improved adaptation to environment and ability to sustain attention, and increased interest in environment and capacity for arousal, without increased aggressiveness.
摘要:
The present invention relates to variable domains of camelid heavy-chain antibodies directed against a glial fibrillary acidic protein and uses thereof for preparing therapeutic or diagnostic agents.
摘要:
Use of a variable fragment of a camelid single-chain antibody (VHH antibody) for the preparation of a peptide vector for delivering a substance of interest across the blood-brain barrier.